Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.585 AUD | 0.00% | +3.54% | +14.71% |
16/04 | Euroz Hartleys Adjusts Argenica Therapeutics’ Price Target to AU$1.40 From AU$1.50, Keeps at Speculative Buy | MT |
12/04 | Argenica Therapeutics Raises AU$12 Million via Placement | MT |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Liz Dallimore
CEO | Chief Executive Officer | - | - |
Emma Waldon
DFI | Director of Finance/CFO | - | - |
Meghan Thomas
CTO | Chief Tech/Sci/R&D Officer | - | 04/22/04 |
Bruno Meloni
CTO | Chief Tech/Sci/R&D Officer | - | - |
Celina Chewas
PRN | Corporate Officer/Principal | - | 22/11 |
Samantha South
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Terry C. Budge
BRD | Director/Board Member | 72 | - |
Geoff Pocock
BRD | Director/Board Member | - | - |
Dianne Angus
BRD | Director/Board Member | 63 | 01/12 |
McCall Liddy
BRD | Director/Board Member | - | - |
Samantha South
PRN | Corporate Officer/Principal | - | - |
Liz Dallimore
CEO | Chief Executive Officer | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 99,150,822 | 87,682,620 ( 88.43 %) | 0 | 88.43 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+14.71% | 47.51M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- AGN Stock
- Company Argenica Therapeutics Limited